{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:51:26Z","timestamp":1782449486323,"version":"3.54.5"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background\/objectives<\/jats:title>\n                    <jats:p>Coronary artery calcification (CAC) is a specific marker of coronary atherosclerotic heart disease, with chronic coronary syndrome (CCS) being a primary clinical manifestation of coronary artery disease. However, research on the plasma metabolites of individuals with CCS and CAC, as well as the identification of candidate markers is scarce. Here we aimed to explore metabolic differences among CAC patients, CCS patients, and healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a study involving 30 patients with CCS (CCS group), 30 with CAC (CAC group), and 30 healthy controls (Control group). Plasma parameters were statistically analyzed. Moreover, metabolomics analysis explored the composition and functions of metabolites in the plasma of each group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that serum creatinine and fasting glucose levels were significantly increased in the CAC group, whereas blood urea nitrogen levels were significantly higher in both the CAC and CCS groups compared with Control group. Significant metabolic differences were observed between the CCS and CAC groups. Further analyses indicated that oleic acid and arachidonic acid were among the metabolites contributing to the separation between CAC patients and healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that plasma metabolite profiles differ among the study groups. The identified metabolites may contribute to distinguishing CAC patients from those with CCS as well as healthy controls, providing additional insights into the metabolic alterations associated with these conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1741496","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:38:05Z","timestamp":1782448685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma metabolic profiling reveals exploratory metabolic differences in chronic coronary syndrome with coronary artery calcification"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoxue","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province","place":["Kunming, Yunnan, China"]},{"name":"Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]},{"name":"Faculty of Life Science and Biotechnology, Kunming University of Science and Technology","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/eurheartj\/ehac640","article-title":"Use of cardiac imaging in chronic coronary syndromes: the EURECA imaging registry","volume":"44","author":"Danilo","year":"2023","journal-title":"Eur Heart"},{"key":"B2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","article-title":"Alterations in the gut microbiome and metabolism with coronary artery disease severity","volume":"7","author":"Liu","year":"2019","journal-title":"Microbiome"},{"key":"B3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-023-01846-z","article-title":"Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome","volume":"22","author":"Wen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.jacc.2018.08.2163","article-title":"Healthy behavior, risk factor control, and survival in the COURAGE trial","volume":"72","author":"Maron","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/14779072.2018.1534069","article-title":"Optimal medical treatment of hypertension in patients with coronary artery disease","volume":"16","author":"Mahtta","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10557-016-6651-8","article-title":"Identifying new risk markers and potential targets for coronary artery disease: the value of the lipidome and metabolome","volume":"30","author":"Laaksonen","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3390\/cells11172663","article-title":"Contribution of oxidative stress (OS) in calcific aortic valve disease (CAVD): from pathophysiology to therapeutic targets","volume":"11","author":"Maria","year":"2022","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/ATVBAHA.113.302642","article-title":"Has our understanding of calcification in human coronary atherosclerosis progressed?","volume":"34","author":"Fumiyuki","year":"2014","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.3109\/07853890.2012.660498","article-title":"Vascular calcification and hypertension: cause and effect","volume":"44","author":"KS","year":"2012","journal-title":"Ann Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.arteri.2024.01.003","article-title":"Lysyl oxidase expression in smooth muscle cells determines the level of intima calcification in hypercholesterolemia-induced atherosclerosis","volume":"36","author":"Servera","year":"2024","journal-title":"Clin Investig Arterioscler"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jacc.2006.04.089","article-title":"Coronary artery calcification and myocardial perfusion in asymptomatic adults","volume":"48","author":"Wang","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the Spectrum of cardiovascular diseases","volume":"78","author":"Giuseppe","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","article-title":"ESC Working group on coronary pathophysiology and microcirculation position paper on \u2018coronary microvascular dysfunction in cardiovascular disease","volume":"116","author":"Teresa","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-023-01819-2","article-title":"Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis","volume":"22","author":"Fuwei","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/jama.291.2.210","article-title":"Coronary artery calcium score combined with framingham score for risk prediction in asymptomatic individuals","volume":"291","author":"Greenland","year":"2004","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"154706","DOI":"10.1016\/j.metabol.2021.154706","article-title":"Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors","volume":"116","author":"Leung","year":"2021","journal-title":"Metab Clin Exp"},{"key":"B18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2215\/CJN.01370211","article-title":"Sclerostin: just one more player in renal bone disease?","volume":"6","author":"Dr\u00fceke","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/hdi.12033","article-title":"Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients","volume":"17","author":"Dong-Mei","year":"2013","journal-title":"Hemodial Int"},{"key":"B20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.acc.2019.07.010","article-title":"Myokines: the endocrine coupling of skeletal muscle and bone","volume":"94","author":"Marta","year":"2020","journal-title":"Adv Clin Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/ATVBAHA.119.312509","article-title":"Hypoxia triggers osteochondrogenic differentiation of vascular smooth muscle cells in an HIF-1 (hypoxia-inducible factor 1)\u2013dependent and reactive oxygen Species\u2013dependent manner","volume":"39","author":"Balogh","year":"2019","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.20039\/j.cnki.1007-3949.2023.04.008","article-title":"Screening and correlation analysis of serum markers related to coronary artery calcification in maintenance hemodialysis patients","volume":"31","author":"Wenli","year":"2023","journal-title":"Chin J Arterioscler"},{"key":"B23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/0003319715574625","article-title":"Increased platelet to lymphocyte ratio is related to slow coronary flow","volume":"67","author":"Akboga","year":"2016","journal-title":"Angiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.thromres.2020.06.003","article-title":"The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention","volume":"194","author":"Sia","year":"2020","journal-title":"Thromb Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"Metaboanalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/ATVBAHA.113.302070","article-title":"Inflammatory, metabolic, and genetic mechanisms of vascular calcification","volume":"34","author":"Demer","year":"2014","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"ehad655.1247","DOI":"10.1093\/eurheartj\/ehad655.1247","article-title":"Low HDL cholesterol and hyperglicemia are metabolic syndrome components associated with plaque progression in patients with chronic coronary syndrome: a PARADIGM study","volume":"44","author":"Neglia","year":"2023","journal-title":"Eur Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events","volume":"3","author":"Shah","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.11817\/j.issn.1672-7347.2021.190172","article-title":"(1)H-NMR-based metabolomics study on coronary heart disease with blood-stasis syndrome and phlegm syndrome","volume":"46","author":"Yi","year":"2021","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2020.04.043","article-title":"Molecular choreography of acute exercise","volume":"181","author":"Contrepois","year":"2020","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e66865","DOI":"10.7554\/eLife.66865","article-title":"Metabolic flexibility via mitochondrial BCAA carrier SLC25A44 is required for optimal fever","volume":"10","author":"Yoneshiro","year":"2021","journal-title":"Elife"},{"key":"B33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/bib\/bbm030","article-title":"Current progress in computational metabolomics","volume":"8","author":"Wishart","year":"2007","journal-title":"Brief Bioinform"},{"key":"B34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.dmpk.2019.07.004","article-title":"Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-fu-zhu-yu decoction in coronary heart disease based on LC-Q-TOF\/MS and GC-MS analysis","volume":"34","author":"Yi","year":"2019","journal-title":"Drug Metab Pharmacokinet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.jpba.2020.113869","article-title":"(1)H NMR-based metabolomics study of the dynamic effect of Xue-fu-zhu-yu capsules on coronary heart disease rats induced by high-fat diet, coronary artery ligation","volume":"195","author":"Zhao","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3389\/fphys.2019.01109","article-title":"NMR Metabolomics and random forests models to identify potential plasma biomarkers of blood stasis syndrome with coronary heart disease patients","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Physiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41590-020-00856-3","article-title":"Microbial metabolism of L-tyrosine protects against allergic airway inflammation","volume":"22","author":"Wypych","year":"2021","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100504","DOI":"10.1016\/j.jlr.2024.100504","article-title":"Spatial lipidomics of coronary atherosclerotic plaque development in a familial hypercholesterolemia swine model","volume":"65","author":"Slijkhuis","year":"2024","journal-title":"J Lipid Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1021\/acs.jmedchem.2c01643","article-title":"Discovery of novel N-hydroxy-1,2,4-oxadiazole-5-formamides as ASM direct inhibitors for the treatment of atherosclerosis","volume":"66","author":"Yang","year":"2023","journal-title":"J Med Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","article-title":"Metabolic predictors of incident coronary heart disease in women","volume":"137","author":"Paynter","year":"2018","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cellsig.2017.02.001","article-title":"Plasma membrane reorganization links acid sphingomyelinase\/ceramide to p38 MAPK pathways in endothelial cells apoptosis","volume":"33","author":"Niaudet","year":"2017","journal-title":"Cell Signal"},{"key":"B43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/2042018810375656","article-title":"Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis","volume":"1","author":"Vangaveti","year":"2010","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0021-9150(02)00391-X","article-title":"Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates","volume":"167","author":"Waddington","year":"2003","journal-title":"Atherosclerosis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/nu10101454","article-title":"Impact of blood or erythrocyte membrane fatty acids for disease risk prediction: focusing on cardiovascular disease and chronic kidney disease","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"key":"B46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jare.2017.11.004","article-title":"Arachidonic acid: physiological roles and potential health benefits\u2014a review","volume":"11","author":"Tallima","year":"2018","journal-title":"J Adv Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/cvr\/cvab003","article-title":"The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis","volume":"117","author":"Badimon","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12944-025-02465-1","article-title":"Arachidonic acid is involved in high-salt diet-induced coronary remodeling through stimulation of the IRE1\u03b1\/XBP1s\/RUNX2\/OPN signaling cascade","volume":"24","author":"Jia","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"632950","DOI":"10.3389\/fmolb.2021.632950","article-title":"Comprehensive metabolomics identified the prominent role of glycerophospholipid metabolism in coronary artery disease progression","volume":"8","author":"Chen","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"101340","DOI":"10.1016\/j.plipres.2025.101340","article-title":"Phospholipids and their metabolites as diagnostic biomarkers of human diseases","volume":"99","author":"Kang","year":"2025","journal-title":"Prog Lipid Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-023-01832-0","article-title":"Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure","volume":"22","author":"Rong","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-006-9280-x","article-title":"Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells","volume":"295","author":"Aiyar","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/ATVBAHA.115.306964","article-title":"Mitochondrial reactive oxygen Species mediate lysophosphatidylcholine-induced endothelial cell activation","volume":"36","author":"Li","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1172\/JCI115932","article-title":"Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells","volume":"90","author":"Kume","year":"1992","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e019300","DOI":"10.1161\/JAHA.120.019300","article-title":"Vascular calcification as a novel risk factor for kidney function deterioration in the nonelderly","volume":"10","author":"Park","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B56","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11914-015-0270-3","article-title":"Molecular mechanisms of vascular calcification in chronic kidney disease: the link between bone and the vasculature","volume":"13","author":"Byon","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"B57","first-page":"1368","article-title":"Analysis of clinical characteristics in patients with intravascular ultrasound-confirmed moderate-to-severe coronary artery calcification","volume":"53","author":"Li","year":"2025","journal-title":"Zhonghua xin xue Guan Bing za zhi"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1741496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:38:12Z","timestamp":1782448692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1741496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":57,"alternative-id":["10.3389\/fcvm.2026.1741496"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1741496","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1741496"}}